| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.45 | 2e-11 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-06 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |